Advertisement

No association between islet cell antibodies and coxsackie B, mumps, rubella and cytomegalovirus antibodies in non-diabetic individuals aged 7–19 years

  • 52 Accesses

  • 9 Citations

Summary

Viral antibodies were tested in a cohort of 44 isletcell antibody-positive individuals age 7–19 years, and 44 of their islet cell antibody-negative age and sex-matched classmates selected from a population study of 4208 pupils who had been screened for islet cell antibodies. Anti-coxsackie B1-5 IgM responses were detected in 14 of 44 (32%) of the islet cell antibody-positive subjects and in 7 of 44 (16%) control subjects. This difference did not reach the level of statistical significance. None of the islet cell antibody-positive subjects had specific IgM antibodies to mumps, rubella, or cytomegalovirus. There was also no increase in the prevalence or the mean titres of anti-mumps-IgG or IgA and anti-cytomegalovirus-IgG in islet cell antibody-positive subjects compared to control subjects. These results do not suggest any association between islet cell antibodies, and possibly insulitis, with recent mumps, rubella or cytomegalo virus infection. Further studies are required to clarify the relationship between islet cell antibodies and coxsackie B virus infections.

References

  1. 1.

    Toniolo A, Federico G, Basolo F, Onodera T (1988) Diabetes mellitus. In: Bendihelli M, Friedman E (eds) Coxsackieviruses: a general update. Plenum Press, New York, pp 351–382

  2. 2.

    Yoon J-W, Austin M, Onodera T, Notkins AL (1979) Virus-induced diabetes mellitus: isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 300: 1173–1179

  3. 3.

    Gladisch R, Hofmann W, Waltherr R (1976) Myokarditis und Insulitis nach Coxsackie-Virus-Infekt. Z Kardiol 65: 837–849

  4. 4.

    Champsaur H, Dussaix E, Samolyk F, Fabre M, Bach C, Assan R (1980) Diabetes and Coxsackie virus B5 infection. Lancet 1: 251

  5. 5.

    Banatvala JE, Bryant H, Scherthaner G et al. (1985) Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Lancet I: 1409–1412

  6. 6.

    Karjalainen J, Knip M, Hyöty H et al. (1988) Relationship between serum insulin autoantibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of Type 1 (insulin-dependent) diabetes. Diabetologia 31: 146–152

  7. 7.

    Tuvemo T, Dahlquist G, Frisk G et al. (1989) The Swedish childhood diabetes study III: IgM against coxsackie B viruses in newly diagnosed Type 1 (insulin-dependent) diabetic children — no evidence of increased antibody frequency. Diabetologia 32: 745–747

  8. 8.

    Frisk G, Folman J, Kobbah M et al. (1985) High frequency of Coxsackie-B-virus-specific IgM in children developing type I diabetes during a period of high diabetes morbidity. J Med Virol 17: 219–227

  9. 9.

    Tuvemo T, Frisk G, Friman G, Ludvigsson J, Diderholm H (1988) IgM against Coxsackie B viruses in children developing type I diabetes mellitus — a seven year retrospective study. Diabetes Res 9: 125–129

  10. 10.

    Tarn A, Thomas JM, Dean BM, Schwarz G, Bottazzo GF, Gale EAM (1988) Predicting insulin-dependent diabetes. Lancet I: 845–850

  11. 11.

    Srikanta S, Ganda OMP, Rabizadeh A, Soeldner JS, Eisenbarth GS (1985) First degree relatives of patients with type I diabetes mellitus: islet cell antibodies and abnormal insulin secretion. N Engl J Med 313: 461–464

  12. 12.

    Riley WJ, MacLaren NK, Krischer J et al. (1990) A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 323: 67–72

  13. 13.

    Wagener DK, Sacks JM, La Porte RE, Macgregor JM (1982) The Pittsburgh study of insulin-dependent diabetes mellitus: risk for diabetes among relatives of IDDM. Diabetes 31: 136–44

  14. 14.

    Kuglin G, Bertrams J, Linke C, Gries FA, Kolb H (1989) Prevalence of cytoplasmatic islet cell antibodies and insulin autoantibodies is increased in subjects with genetically defined high risk for insulin-dependent diabetes mellitus. Klin Wochenschr 67: 66–73

  15. 15.

    Seißler J, Speck U, Glück M et al. (1990) Epidemiologische Untersuchung zur Erkennung der präklinischen Phase des Typ I Diabetes bei Schulkindern. Populationsstudie Ulm-Frankfurt. Dtsch Med Wochenschr 115: 689–694

  16. 16.

    Scherbaum WA, Mirakian R, Pujol-Borrell R, Dean BM, Bottazzo GF (1986) Immunochemistry in the study and diagnosis of organ-specific autoimmune diseases. In: Polak JM, Van Noorden S (eds) Immunochemistry. Modern methods and applications. Wright, Bristol pp 456–476

  17. 17.

    Bonifacio E, Lernmark Å, Dawkins RL et al. (1988) Serum exchange and use of dilutions have improved precision of measurement of islet cell antibodies. J Immunol Method 106: 83–88

  18. 18.

    Antoniadis G, Enders G, Lennartz H, Thomssen R (1974) Standardisierte Technik zur Durchführung des Röteln-HA und HAH-Testes. Bundesgesundheitsblatt 17: 329–335

  19. 19.

    Helmke K, Otten A, Willems W (1980) Islet cell antibodies in children with mumps infection. Lancet II: 211–212 (Letter)

  20. 20.

    Ratzmann KP, Strese J, Witt S, Berling H, Keilacker H, Michaelis D (1984) Mumps infections and insulin-dependent diabetes mellitus (IDDM). Diab Care 7: 170–173

  21. 21.

    Rayfield EJ, Seto Y (1978) Viruses and the pathogenesis of diabetes mellitus. Diabetes 27: 1126–1142

  22. 22.

    King ML, Bidwell D, Shaikh A, Voller A, Banatvala JE (1983) Coxsackie-B-virus-specific IgM responses in children with insulin-dependent (juvenile-onset; type 1) diabetes mellitus. Lancet I: 1397–1399

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Scherbaum, W.A., Hampl, W., Muir, P. et al. No association between islet cell antibodies and coxsackie B, mumps, rubella and cytomegalovirus antibodies in non-diabetic individuals aged 7–19 years. Diabetologia 34, 835–838 (1991). https://doi.org/10.1007/BF00408360

Download citation

Key words

  • Viral antibodies
  • Beta-cell function
  • population study